Aldebaran Therapeutics leverages human genetics and best-in-class antisense oligonucleotide (ASO) technology to deliver life-changing, precision ocular ASO medicines. Our focus on differentiated ASO technology, powered by Alloy Therapeutics' Genetic Medicines platform and novel AntiClastic™ ASO format, paves the way for a unique and rapid path to meaningful ocular solutions for patients.
Company Details
- Employees
- 5
- Address
- Waltham, Massachusetts
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://aldebarantx.com
- HQ
- Waltham, Massachusetts
Aldebaran Therapeutics Questions
Aldebaran Therapeutics's website is http://aldebarantx.com
Aldebaran Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aldebaran-therapeutics
Aldebaran Therapeutics has
5 employees.
View email and phone details for 5
employees at Aldebaran Therapeutics.
Aldebaran Therapeutics's industry is
Biotechnology Research
Aldebaran Therapeutics's top competitors are
Quiver Bioscience,
Maze Therapeutics,
Broadwing Bio,
Prevail Therapeutics,
Eisai Us,
Aakha Biologics,
Quralis,
Leal Therapeutics,
Arnay Sciences,
Alloy Therapeutics, Inc..
Aldebaran Therapeutics's categories are Biotechnology Research
